FIELD: medicine. SUBSTANCE: the innovation deals with the methods to detect and use inhibiting factors of a stem cell to regulate abnormal stem cell cycle and acceleration of peripheral blood cell recovery during and after chemotherapy period. It is also discovered the methods for treatment and vaccination. Innovation includes inhibitors of stem cell proliferation, as well. EFFECT: broadened variety of inhibiting preparations. 54 cl, 19 tbl, 21 dwg
Title | Year | Author | Number |
---|---|---|---|
STEM CELL PROLIFERATION INHIBITOR AND STIMULANT AND USAGE THEREOF | 1997 |
|
RU2292352C9 |
GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2799086C2 |
RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND WAYS OF USE THEREOF | 2020 |
|
RU2816370C2 |
HEMATOPOIETIC PRECURSOR CELL DIFFERENTIATION INHIBITOR | 2006 |
|
RU2317074C1 |
COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE ERYTHROCYTE COUNT | 2020 |
|
RU2814047C2 |
VIRUS-MEDIATED ENHANCED TRANSFER OF DNA | 1995 |
|
RU2174846C2 |
USEFUL LOAD DELIVERY TO STEM CELLS | 2018 |
|
RU2795155C1 |
IMMUNOMODULATING OLIGOPEPTIDES | 2007 |
|
RU2503684C2 |
TREATMENT OF MALIGNANT TUMOR USING ANTI-CD19 ANTIGEN CHIMERIC RECEPTOR | 2015 |
|
RU2815417C2 |
COMBINATION THERAPY FOR THE TREATMENT OF BCMA-RELATED CANCER AND AUTOIMMUNE DISORDERS | 2018 |
|
RU2799762C2 |
Authors
Dates
2002-08-10—Published
1995-09-29—Filed